These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Editorial: Osteoclastic bone resorption and the hypercalcemia of cancer. Brewer HB N Engl J Med; 1974 Nov; 291(20):1081-2. PubMed ID: 4412968 [No Abstract] [Full Text] [Related]
3. Cancer and hypercalcemia of malignancy: a change in focus. Muggia F Semin Oncol; 1991 Aug; 18(4 Suppl 5):1-2. PubMed ID: 1925623 [No Abstract] [Full Text] [Related]
4. New diphosphonates to block bone resorption. Raisz LG N Engl J Med; 1980 Feb; 302(6):347-8. PubMed ID: 6444242 [No Abstract] [Full Text] [Related]
5. Editorial: Tumor humors and the hypercalcemias of cancer. Tashjian AH N Engl J Med; 1974 Apr; 290(16):905-6. PubMed ID: 4816965 [No Abstract] [Full Text] [Related]
6. [Effect of hydrochlorothiazide on various parameters of calcium and phosphate metabolism in patients with increased bone resorption caused by malignant metastases to the skeleton]. Gasińska T; Rozek-Lesiak K; Harbut-Gryłka A Pol Tyg Lek; 1979 Sep; 34(38):1499-502. PubMed ID: 503956 [No Abstract] [Full Text] [Related]
10. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption. Alvarez E; Westmore M; Galvin RJ; Clapp CL; Considine EL; Smith SJ; Keyes K; Iversen PW; Delafuente DM; Sulaimon S; Zambrano C; Ma L; Sato M; Martin TJ; Teicher BA; Galbreath EJ Clin Cancer Res; 2003 Nov; 9(15):5705-13. PubMed ID: 14654555 [TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy. Oyajobi BO; Anderson DM; Traianedes K; Williams PJ; Yoneda T; Mundy GR Cancer Res; 2001 Mar; 61(6):2572-8. PubMed ID: 11289133 [TBL] [Abstract][Full Text] [Related]
13. [Significance of prostaglandins for tumor growth and tumor symptoms]. Peskar BM Med Klin; 1981 Jan; 76(1):11-4. PubMed ID: 7019649 [No Abstract] [Full Text] [Related]
14. Mediators of bone resorption and hypercalcemia in cancer. Pugliese G N Engl J Med; 1988 Mar; 318(10):642-3. PubMed ID: 3344013 [No Abstract] [Full Text] [Related]
15. Prostaglandins and the hypercalcemia of cancer. Raisz LG N Engl J Med; 1973 Jul; 289(4):214-5. PubMed ID: 4712993 [No Abstract] [Full Text] [Related]
16. [Editorial: Mechanisms of osteolysis and hypercalcemia of cancer]. Lemaire V; Ryckewaert A Nouv Presse Med; 1975 Dec; 4(45):3167-8. PubMed ID: 1221363 [No Abstract] [Full Text] [Related]
17. In vitro osteolysis by human breast tumours. Easty GC; Dowsett M; Powles TJ; Easty DM; Gazet JC; Neville AM Proc R Soc Med; 1977 Mar; 70(3):191-5. PubMed ID: 193116 [No Abstract] [Full Text] [Related]
18. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822 [TBL] [Abstract][Full Text] [Related]
19. Prostaglandin-induced bone resorption by rheumatoid synovia. Robinson DR; Tashjian AH; Levine L Trans Assoc Am Physicians; 1975; 88():146-60. PubMed ID: 1224433 [No Abstract] [Full Text] [Related]
20. Hypercalcemia and lytic bone lesions in a patient with B-cell non-Hodgkin's lymphoma. Jacobs RH; Larson RA; LeBeau M; Kluskens LF; Vardiman JW; Rowley JD; Golomb HM N Engl J Med; 1984 Jan; 310(4):263-4. PubMed ID: 6318111 [No Abstract] [Full Text] [Related] [Next] [New Search]